Could Fampridine Attenuate the Severity of COVID-19 in Patients with Multiple Sclerosis? Abdorreza Naser Moghadasi Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran. Nassim Anjidani Medical Department, Orchid Pharmed Company, Tehran, Iran. Fereshteh Rashvand OrchidLife Patient Support Service, Orchid Pharmed, Tehran, Iran. DOI: https://doi.org/10.18502/fem.v5i3.5888 Abstract The article's abstract is not available. PDF Published 2021-04-04 Issue Volume (5) issue (3) Section Articles
